Chelsea Therapeutics (NASDAQ:CHTP): An Orphan Likely To Be Adopted Soon; $18 target – Roth

Roth Capital’s David Moskowitz, RPh. is making an interesting call on Chelsea Therapeutics (NASDAQ:CHTP) raising his target on the small-cap biotech to $18 (up from $6). - It looks like CHTP has significant catalysts ahead. Here are some excerpts from the call (15pg): * Strong Buzz On Northera At the Movement Disorder Society (MDS) Conference. [...]